In our present study, we further demonstrated that the pharmacological effects and mechanisms of LSN in protecting against MI were via preventing inflammation-induced cardiomyocyte injury and inhibiting adverse Wnt/β-catenin signaling activation. The gene discussed is SPN; the disease is myocardial infarction.